BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38465959)

  • 1. Pulmonary Recurrence of Colorectal Mucinous Adenocarcinoma and Sarcoidosis on 18 F-FDG PET/CT.
    Habouzit V; Maoui K; Prevot N; Forest F; Grange R
    Clin Nucl Med; 2024 May; 49(5):475-477. PubMed ID: 38465959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in postoperative patients with gastrointestinal mucinous adenocarcinoma.
    Yang ZY; Hu SL; Shi W; Zhu BL; Xu JY; Zhang YJ
    Nucl Med Commun; 2011 Nov; 32(11):1018-25. PubMed ID: 21956489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.
    Whiteford MH; Whiteford HM; Yee LF; Ogunbiyi OA; Dehdashti F; Siegel BA; Birnbaum EH; Fleshman JW; Kodner IJ; Read TE
    Dis Colon Rectum; 2000 Jun; 43(6):759-67; discussion 767-70. PubMed ID: 10859074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role of 18F-fluorodeoxyglucose positron emission/computed tomography in a strategy for abdominal wall metastasis of colorectal mucinous adenocarcinoma developed after laparoscopic surgery.
    Funahashi K; Ushigome M; Kaneko H
    World J Surg Oncol; 2011 Feb; 9():28. PubMed ID: 21352607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
    Deleau C; Buecher B; Rousseau C; Kraeber-Bodéré F; Flamant M; des Varannes SB; Frampas E; Galmiche JP; Matysiak-Budnik T
    Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):275-81. PubMed ID: 21304319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of semiquantitative analysis in local recurrence of colorectal carcinoma with
    Gedik GK; Yilmaz F
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(6):366-372. PubMed ID: 30193775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can (18)F-FDG PET/CT scan change treatment planning and be prognostic in recurrent colorectal carcinoma? A prospective and follow-up study.
    Artiko V; Odalovic S; Sobic-Saranovic D; Petrovic M; Stojiljkovic M; Petrovic N; Kozarevic N; Grozdic-Milojevic I; Obradovic V
    Hell J Nucl Med; 2015; 18(1):35-41. PubMed ID: 25840571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of computed tomography and
    Kaneko M; Kawai K; Nozawa H; Hata K; Tanaka T; Nishikawa T; Shuno Y; Sasaki K; Emoto S; Murono K; Ishii H; Sonoda H; Watadani T; Takao H; Abe O; Ishihara S
    Colorectal Dis; 2020 Dec; 22(12):1984-1990. PubMed ID: 32780478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidental focal uptake in colorectal location on oncologic ¹⁸FDG PET and PET/CT studies: histopathological findings and clinical significances.
    Fuertes J; Montagut C; Bullich S; Coma MI; Mestre-Fusco A; Suárez-Piñera M; Trampal C; Bellmunt J
    Rev Esp Med Nucl Imagen Mol; 2015; 34(2):95-101. PubMed ID: 25263718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of dual-time
    Pahk K; Chung JH; Kim S; Lee SH
    Tumori; 2018 Jun; 104(3):207-212. PubMed ID: 29714664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
    Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
    Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of (18)F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA.
    Gade M; Kubik M; Fisker RV; Thorlacius-Ussing O; Petersen LJ
    Cancer Imaging; 2015 Aug; 15(1):11. PubMed ID: 26263901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer.
    Laurens ST; Oyen WJ
    PET Clin; 2015 Jul; 10(3):345-60. PubMed ID: 26099671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Value of (18)F-FDG PET/CT in Detecting Local Recurrent Colorectal Cancer: A Pooled Analysis of 26 Individual Studies.
    Yu T; Meng N; Chi D; Zhao Y; Wang K; Luo Y
    Cell Biochem Biophys; 2015 Jun; 72(2):443-51. PubMed ID: 25737131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Value of (18)F-FDG- PET-CT in the Preoperative Staging of Peritoneal Carcinomatosis from Colorectal Origin.
    De Vos N; Goethals I; Ceelen W
    Acta Chir Belg; 2014; 114(6):370-5. PubMed ID: 26021680
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Chauvelot P; Skanjeti A; Jamilloux Y; de Parisot A; Broussolle C; Denis P; Ramackers JM; Giammarile F; Kodjikian L; Seve P
    Br J Ophthalmol; 2019 Nov; 103(11):1650-1655. PubMed ID: 30658987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Pulmonary Mucinous Adenocarcinoma Was Better Visualized on Delayed FDG PET/CT Imaging.
    Zheng N; Bai X; Niu R; Wang X
    Clin Nucl Med; 2016 Oct; 41(10):809-11. PubMed ID: 27454595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography in mucinous adenocarcinoma.
    Murakami S; Saito H; Karino F; Kondo T; Oshita F; Ito H; Nakayama H; Yokose T; Yamada K
    Eur J Radiol; 2013 Nov; 82(11):e721-5. PubMed ID: 23988690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal Mucinous Tubular and Spindle Cell Carcinoma Shows a High Uptake on
    Furuya S; Manabe O; Nanbu T; Yamashita N; Shinnno Y; Kasai K; Kroenke M; Tamaki N
    Intern Med; 2018 Apr; 57(8):1131-1134. PubMed ID: 29279490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous use of FDG-18 and
    Tetikkurt C; Sayman H; Dedeoglu SE; Kubat B; Tetikkurt S
    Monaldi Arch Chest Dis; 2020 Jul; 90(3):. PubMed ID: 32724228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.